We examined the epidemiology of invasive penicillin-resistant Streptococcus pneumoniae (PRSP) infections among residents of the Baltimore metropolitan area from 1995 through 1997. During this period, the proportion PRSP cases increased 42%, from 5.7% to 8.1% of cases. PRSP rates were highest among persons aged !5 and у65 years, black patients, and urban dwellers. However, the proportion of PRSP cases was higher among white persons (10%) than it was among black persons (5%) and among residents of suburban counties (10%) versus urban counties (6%). PRSP cases were more common in November-April (8%) than they were in May-October (5%), particularly for persons aged у65 years (10% vs. 1%). By use of logistic regression, white race, suburban residence, and winter respiratory season were found to be independent predictors of infection with PRSP. The incidence of PRSP is increasing in Baltimore, and the seasonality of PRSP suggests that recent antibiotic use, which is more common in winter months, may rapidly affect the prevalence of resistant pneumococcal infections.
fatality ratio from population-based surveillance of ∼10% [11] .
Reports of pneumococcal infections with strains that have intermediate and high-level resistance to penicillin began to emerge in the United States during the 1980s [12] [13] [14] [15] . In 1997, data from the Centers for Disease Control and Prevention's (CDC) Emerging Infections Program demonstrated that 25% of invasive pneumococcal isolates were nonsusceptible to penicillin and 14% were resistant to penicillin [16] . There is also marked geographic variation in the prevalence of penicillin-resistant S. pneumoniae (PRSP) across the United States, ranging from as low as 2% to as high as 35%, thereby emphasizing the importance of communitybased surveillance of pneumococcal susceptibility [9, 10, [17] [18] [19] .
Studies published elsewhere have identified white persons, young children, and suburban residents as high-risk groups for PRSP disease [9, [20] [21] [22] . It has been speculated that these demographic characteristics are surrogates for socioeconomic status, access to medical care, and use of antibiotics. We describe the epidemiology of PRSP in the Baltimore metropolitan area (BMA) from 1995 through 1997, and we identify risk factors associated with PRSP.
MATERIALS AND METHODS

Surveillance for invasive pneumococcal infection.
Active surveillance for invasive pneumococcal infection was initiated in the BMA on 1 January 1995, as part of the Maryland Bacterial Invasive Disease Surveillance project (BIDS) [10, 23] . BIDS is the Active Bacterial Core Surveillance component of the multistate Emerging Infections Program Network, which is coordinated by the CDC. The BMA consists of the jurisdictions of Baltimore City and Baltimore, Anne Arundel, Carroll, Harford, and Howard counties, and it accounts for half of Maryland's population of 5 million people. The surveillance case definition is the isolation of S. pneumoniae from a specimen of normally sterile body fluid, such as blood or CSF, obtained from a BMA resident of any age. All acute-care hospitals in the BMA participate, as do other microbiology laboratories that process blood cultures. For each eligible case patient, the hospital infection control professional completes a 1-page case report form, which includes demographic (e.g., sex and race) and brief clinical information, and the bacterial isolate is submitted for species confirmation and further testing. Calls are made to hospital infection control practitioners to ascertain cases not reported spontaneously. Microbiology laboratory audits to identify unreported cases are performed twice yearly by BIDS staff by review of the laboratory records. Minimum inhibitory concentrations (MICs) were determined by a reference laboratory at the University of Texas at San Antonio, by use of standard methods [24] . "Resistance to penicillin" was defined as an MIC of у2.0 mg/mL, and "intermediate nonsusceptibility" to penicillin was defined as an MIC of 0.12-1.0 mg/mL [25] .
Statistical analysis. The analysis focused exclusively on PRSP (MIC of penicillin, у2.0 mg/mL) disease in the BMA from 1995 through 1997. Age, race, and county-specific midyear population estimates for Maryland for 1996 were obtained from the CDC Wonder database (http://wonder.cdc.gov/censJ .shtml). Patient race was divided into the categories of white, black, and other. "Urban Baltimore" was defined as the jurisdiction of Baltimore City, and "suburban Baltimore" was defined as the counties of Anne Arundel, Baltimore, Carroll, Harford, and Howard. The "winter respiratory season" was defined as the months of November-April, and the "nonrespiratory season" was defined as May-October. Because not all invasive SPN cases had an isolate available for MIC testing, rates of PRSP were calculated by multiplying the rate of SPN by the proportion of cases due to PRSP. The MIC distribution for cases without available isolates was assumed to be the same as that of the tested isolates. All other analyses specifically for PRSP infections were performed on the patients for whom MIC data were available.
x 2 and Fisher exact tests were used for comparison of rates and proportions with a 2-sided significance level of 0.05. Univariate and multivariate logistic regression was performed to determine the odds of PRSP among patients with invasive SPN disease; categorical variables were used for age, race, urban setting, and respiratory season. Data were analyzed by use of Stata Statistical Software, version 6.0 (Stata Corporation).
RESULTS
For the period of 1 January 1995 through 31 December 1997, a total of 2094 patients with invasive SPN disease were identified in the BMA; 683 cases were from 1995, 729 cases were from 1996, and 682 cases were from 1997. MICs were determined for the isolates recovered from 1693 (81%) of these patients. Patients with and patients without MIC data were similar with regard to age, sex, county of residence, race, type of infection, and underlying illness. Table 1 outlines the demographic characteristics of patients with invasive pneumococcal infections. Patients ranged in age from 0 days to 101 years. Among patients with invasive SPN disease, 1120 patients (53%) were male, 1107 (53%) were black, and 1240 (59%) resided in urban Baltimore City.
Among children aged 0-4 years with invasive pneumococcal disease, 82% had no recorded underlying illness, compared with 32% of persons aged у5 years. The most frequently reported comorbid conditions for children aged 0-4 years were HIV/ AIDS (in 13 ). The overall case fatality rate for invasive pneumococcal disease was 8% (157 deaths per 2071 cases); it varied from 2% in children aged 0-4 years to 13% in persons aged у65 years.
For the 3-year period, 126 isolates (7.4%) were resistant to penicillin and 126 isolates (7.4%) had intermediate nonsusceptibility to penicillin. From 1995 through 1997, the proportion of pneumococcal isolates that were resistant to penicillin increased 42%, from 5.7% to 8.1% of cases. For 20-44-yearold persons, during the 3-year surveillance period, the proportion of PRSP infections increased from 1.8% to 10.8% (trend test for odds, ); for black patients, this pro-P ! 0.001 portion increased from 3.2% to 7.1% (trend test for odds, ); and for urban dwellers, the increase in PRSP in-P p 0.04 fections was from 3.2% to 7.4% (trend test for odds, P p ). Table 2 shows the patterns of antimicrobial susceptibility 0.02 for the pneumococcal isolates. Among isolates that were resistant to penicillin, 90% were also resistant to cotrimoxazole, 39% were resistant to erythromycin, 38% were resistant to cefotaxime, and 6% were resistant to ofloxacin. All isolates were susceptible to vancomycin.
The average annual incidence of invasive pneumococcal disease in the BMA was 28.7 cases per 100,000 population; the annual incidence for PRSP was 2.1 cases per 100,000 (table 1) . Children aged 0-4 years and adults aged у65 years had both the highest incidence of pneumococcal disease (75.1 and 66.7 cases per 100,000 population, respectively) and PRSP disease (5.6 and 5.1 cases per 100,000 population, respectively). The PRSP incidence for persons aged 5-64 years was 1.4 cases per 100,000 population ( vs. either age of 0-4 years or P ! 0.001 у65 years). The overall case fatality rate for patients with PRSP was 10.5% (13 deaths per 124 cases), ranging from 5% in young children aged 0-4 years to 14% in persons aged у65 years.
The incidence of invasive SPN disease was 55.2 cases per 100,000 population for black patients, compared with 18.3 cases per 100,000 population among white patients (risk ratio, 3.0; 95% CI, 2.6-3.5; ); 10% of white patients were infected P ! 0.001 with penicillin-resistant strains, compared with 5% of black patients ( ); however, the incidence of PRSP in black P ! 0.001 patients was 2.9 cases per 100,000 population, in contrast with 1.8 cases per 100,000 population among white patients (risk ratio, 1.6; 95% CI, 0.9-3.0; ). For both black patients P p 0.11 and white patients, the incidence of PRSP remained highest for children aged 0-4 years and у65 years (figure 1).
Ten percent of the cases of invasive pneumococcal disease among residents of the 5 suburban BMA counties were caused by penicillin-resistant strains, compared with 6% of cases from urban Baltimore City (  ; table 1 ). In contrast, the in-P p 0.001 cidence of PRSP in Baltimore City was 3.5 cases per 100,000 population, compared with 1.6 cases per 100,000 population in the suburban counties (risk ratio 2.2; 95% CI, 1.2-3.8; ). P p 0.007 A higher proportion of the cases of invasive SPN disease that occurred during the winter respiratory season were caused by penicillin-resistant strains, as compared with the nonrespiratory season (8% vs. 5%;
). In particular, children aged 0-4 P p 0.03 years and adults aged у65 years had a greater proportion of cases caused by PRSP during the respiratory season (figure 2). The OR for PRSP in respiratory versus nonrespiratory months in persons aged у65 years was 8.4 (95% CI, 2.0-35.4; P ! ); for persons of all ages, the OR was 1.6 (95% CI, 1.1-2.5; 0.001 ). P p 0.027
Univariate and multivariate logistic regression models were fitted to determine factors associated with the frequency of PRSP among patients with invasive pneumococcal disease. Race, county of residence, and season were found to be significant predictors of infection with PRSP (table 3) . After adjustment for age, county, and season, the odds of PRSP were 60% greater among white patients than they were among black patients ( ). Suburban dwellers had 60% higher ad-P p 0.04 justed odds of PRSP than did urban dwellers ( ). The P p 0.03 adjusted odds for PRSP were 1.6 times greater in the respiratory season than they were in the nonrespiratory season (P p ). In the model, no interaction was found between race 0.04 and county or between age and race. When the regression model was used, the predicted probability of PRSP was ∼4 times higher for a white, suburban resident in the winter than a black, urban resident in the nonwinter season (table 4) .
DISCUSSION
In this study, PRSP was independently associated with white race, suburban residence, and winter season. To the best of our knowledge, the finding of seasonal variability in PRSP has not been previously reported. We found that the odds of PRSP were 60% higher during the winter respiratory season than they were during the rest of the year for all age groups combined, and that this effect was most pronounced in elderly persons. An- 
NOTE.
Nonrespiratory, May-October; respiratory, November-April.
a Referent group.
tibiotic exposure is a major risk factor for PRSP disease [20, 21, [26] [27] [28] [29] [30] [31] [32] . Of interest, the seasonal differences in PRSP we observed strongly correlate with trends in antibiotic use in Baltimore, where antibiotics are much more frequently prescribed during the winter season [33] . These data strongly suggest that increased antibiotic pressure during the respiratory season is responsible for the higher frequency of PRSP during that time of the year. Although we did not directly measure antibiotic exposure among demographic groups in our study, we believe that differential antibiotic use may play an important role in the observed differences in PRSP in Baltimore. Furthermore, the lower frequency of PRSP during May through October may indicate that a reduction in antibiotic pressure results in a relatively rapid decline in antibiotic resistance, a positive finding for programs that promote the judicious use of antibiotics, which is consistent with previous studies of PRSP that have demonstrated a prompt reduction in resistance after a decrease in antibiotic use [34, 35] . Overall, the prevalence of PRSP is increasing in Baltimore, as it is in many other geographic regions in the United States [11] [12] [13] [14] [15] [16] [17] [18] 22] . Of importance, statistically significant increases were observed in our study for persons aged 20-44 years, for black individuals, and for urban dwellers, groups in which the prevalence of PRSP has historically been relatively low. Of interest, the overall frequency of penicillin-nonsusceptible S. pneumoniae (both intermediate and resistant isolates) did not increase from 1995 through 1997, remaining relatively constant at 15%. This pattern, in which the ratio of resistant to nonsusceptible isolates increases over time, has been described elsewhere [11, 12, 15, 18, 22] .
As has been shown in other studies, the highest proportion of pneumococcal infections with resistant strains in the BMA was among white patients [9, 22] . However, this fact obscures the problem of PRSP among black patients, because, in our study, the incidence of PRSP, which is a product of the incidence of pneumococcal infection and the proportion of disease due to PRSP, was actually higher in black patients than it was in white patients. As a result, black individuals and urban dwellers bear a substantial burden of resistant pneumococcal disease in the BMA.
With the continued spread of PRSP and the increasing limitation of treatment options, efforts should be directed at the prevention of resistant pneumococcal infections. Broad educational programs directed at promoting judicious antibiotic use have been developed, including an intervention currently under evaluation in Baltimore [33] [34] [35] [36] [37] [38] . Gonzales et al. [36] demonstrated that antibiotic prescribing for adults with acute bronchitis could be reduced by use of office-based and household educational methods. This study was effective in a groupmodel, health management organization setting in Colorado. However, on the basis of our data, designing an intervention to maximize impact on antibiotic-prescribing patterns and PRSP disease is challenging, given the demographic and geographic variation in disease. Programs that focus on suburban communities with a high proportion of PRSP disease may miss an opportunity to reduce a significant burden of PRSP disease that occurs in urban settings. The higher incidence of PRSP among black patients and the increasing proportion of invasive pneumococcal infections that are PRSP in this demographic group strongly suggest that judicious antibiotic use interventions should include urban populations. Additional studies are also needed to demonstrate whether educational interventions that reduce inappropriate use of antibiotics can lead to a sustained reduction in the incidence of PRSP disease.
